1. 270 A phase II basket trial of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART) SWOG S1609: the thyroid tumor cohort. (9th November 2020) Authors: Chae, Young Kwang; Othus, Megan; Patel, Sandip; Fenton, Sarah; Wang, Ding; Rodriguez, Cristina; Onitilo, Adedayo; Mattour, Ahmad; Rybkin, Igor; Hayward, Jourdain; McLeod, Christine; Chen, Helen; Sharon, Elad; Mayerson, Edward; Ryan, Christopher; Plets, Melissa; Blanke, Charles; Kurzrock, Razelle Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A288 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 270 A phase II basket trial of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART) SWOG S1609: the thyroid tumor cohort. (9th November 2020) Authors: Chae, Young Kwang; Othus, Megan; Patel, Sandip; Fenton, Sarah; Wang, Ding; Rodriguez, Cristina; Onitilo, Adedayo; Mattour, Ahmad; Rybkin, Igor; Hayward, Jourdain; McLeod, Christine; Chen, Helen; Sharon, Elad; Mayerson, Edward; Ryan, Christopher; Plets, Melissa; Blanke, Charles; Kurzrock, Razelle Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A161 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 795 A multicenter phase II trial (SWOG S1609, cohort 51) of ipilimumab and nivolumab in metastatic or unresectable angiosarcoma: a substudy of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART). (9th November 2020) Authors: Wagner, Michael; Othus, Megan; Patel, Sandip; Ryan, Christopher; Sangal, Ashish; Powers, Benjamin; Budd, George; Victor, Adrienne; Hsueh, Chung-Tsen; Chugh, Rashmi; Nair, Suresh; Leu, Kirsten; Agulnik, Mark; Sharon, Elad; Mayerson, Edward; Plets, Melissa; Blanke, Charles; Streicher, Howard; Chae,... Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A475 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 795 A multicenter phase II trial (SWOG S1609, cohort 51) of ipilimumab and nivolumab in metastatic or unresectable angiosarcoma: a substudy of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART). (9th November 2020) Authors: Wagner, Michael; Othus, Megan; Patel, Sandip; Ryan, Christopher; Sangal, Ashish; Powers, Benjamin; Budd, George; Victor, Adrienne; Hsueh, Chung-Tsen; Chugh, Rashmi; Nair, Suresh; Leu, Kirsten; Agulnik, Mark; Sharon, Elad; Mayerson, Edward; Plets, Melissa; Blanke, Charles; Streicher, Howard; Chae,... Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A843 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. A comparison of sunitinib with cabozantinib, crizotinib, and savolitinib for treatment of advanced papillary renal cell carcinoma: a randomised, open-label, phase 2 trial. Issue 10275 (20th February 2021) Authors: Pal, Sumanta K; Tangen, Catherine; Thompson, Ian M; Balzer-Haas, Naomi; George, Daniel J; Heng, Daniel Y C; Shuch, Brian; Stein, Mark; Tretiakova, Maria; Humphrey, Peter; Adeniran, Adebowale; Narayan, Vivek; Bjarnason, Georg A; Vaishampayan, Ulka; Alva, Ajjai; Zhang, Tian; Cole, Scott; Plets, Mel... Journal: Lancet Issue: Volume 397:Issue 10275(2021) Page Start: 695 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. A phase II basket trial of Dual Anti–CTLA–4 and Anti–PD–1 Blockade in Rare Tumors (DART) SWOG S1609: High‐grade neuroendocrine neoplasm cohort. Issue 17 (21st April 2021) Authors: Patel, Sandip Pravin; Mayerson, Edward; Chae, Young Kwang; Strosberg, Jonathan; Wang, Jue; Konda, Bhavana; Hayward, Jourdain; McLeod, Christine M.; Chen, Helen X.; Sharon, Elad; Othus, Megan; Ryan, Christopher W.; Plets, Melissa; Blanke, Charles D.; Kurzrock, Razelle Journal: Cancer Issue: Volume 127:Issue 17(2021) Page Start: 3194 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Circulating microRNAs and treatment response in the Phase II SWOG S0925 study for patients with new metastatic hormone‐sensitive prostate cancer. Issue 2 (6th November 2017) Authors: Cheng, Heather H.; Plets, Melissa; Li, Hongli; Higano, Celestia S.; Tangen, Catherine M.; Agarwal, Neeraj; Vogelzang, Nicholas J.; Hussain, Maha; Thompson, Ian M.; Tewari, Muneesh; Yu, Evan Y. Journal: Prostate Issue: Volume 78:Issue 2(2018) Page Start: 121 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗